title: Transmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection.
authors.forename: Philippe
authors.initials: P
authors.lastname: Colson
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ravaux
authors.forename: Nouara
authors.initials: N
authors.lastname: Yahi
authors.forename: Christian
authors.initials: C
authors.lastname: Tourrès
authors.forename: Hervé
authors.initials: H
authors.lastname: Gallais
authors.forename: Catherine
authors.initials: C
authors.lastname: Tamalet
mesh_terms: D019943:Amino Acid Substitution; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics; D005260:Female; D014644:Genetic Variation; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission* / Q000821:virology; D016333:HIV Protease / Q000235:genetics; D054303:HIV Reverse Transcriptase / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation
chemical_list: D019380:Anti-HIV Agents; D054303:HIV Reverse Transcriptase; D016333:HIV Protease